Melanoma Institute Australia

2026 TCS Sydney Marathon presented by ASICS
2026-08-30
Whether you’re chasing your debut or your next star, the TCS Sydney Marathon presented by ASICS is your moment to shine.
Sydney is the bucket-list race that redefines what’s possible, so come experience the place where the world comes to finish.
When you nominate MIA as your charity of choice, funds raised support our life-saving melanoma research, so we can reach our mission of zero deaths from melanoma.
Make sure you set up your fundraising page, as well as registering for the event – both can be done at the link below.
REGISTER NOW

European Congress of Pathology
2026-09-12 - 2026-09-16 | Stockholmsmässan, Mässvägen 1, Älvsjö, 12530, Sweden
The European Society of Pathology (ESP) and the Swedish Society of Pathology are delighted to invite you to the 38th European Congress of Pathology (ECP 2026), to be held at Stockholmsmässan, from 12 –16 September 2026, in the heart of Sweden’s capital.
ECP 2026 will bring together more than 5,000 participants from all over the world—pathologists, clinicians, researchers, molecular biologists, bioinformaticians, medical scientists, and industry partners. The meeting will provide an ideal opportunity for professional development, networking, to exchange insights, and will demonstrate the commitment of the ESP to contributing to Pathology progress in the near future.
The motto of the congress – “Innovation Driving Excellence in Pathology” –acknowledges the significant improvement that pathology innovation has brought and continues to bring to diagnostics, assessment of prognosis and therapy response prediction and clinical practice. The excellent programme prepared by the ESP working groups, ESP-affiliated societies, education and trainee committees, and other collaborating societies will include keynote lectures, slide seminars, symposia, and interactive workshops, from internationally renowned speakers and leaders in their fields. There will be a special focus on digital pathology, AI integration, and emerging technologies that are transforming our field.
Location: Stockholmsmässan, Stockholm, Sweden
Key Dates:
Abstract submission deadline: 8 April 2026
Abstract notifications: early June 2026
Registration and payment deadline for authors of accepted abstracts: 25 June 2026
FIND OUT MORE

ABNA Annual Conference
2026-09-16 - 2026-09-18 | Crowne Plaza Hobart, 110 Liverpool Street, Hobart, Tasmania, 7000, Australia
ABNA’s Annual Conference “From Collection to Discovery: Enabling Research, Accelerating Impact” will be held in Hobart, 16-18 September 2026.
The star event in the annual ABNA calendar, this meeting provides an opportunity to connect with biobankers and biospecimen scientists from around the world to discuss shared strategies to shape the future of biobanking. The 2026 program will once again foster professional growth and encourage a commitment to excellence through expert talks exploring novel approaches to traditional biospecimen science as well as and cutting-edge biobanking technology.
Enjoy workshops, special interest group meetings, rapid fire presentations, poster displays, and elevator pitch presentations as well as a range of networking events including biobanker speed networking, a site visit and gala dinner to facilitate collaborations with researchers, policymakers, corporate sponsors and industry leaders to drive innovation and partnership.
Don’t miss this chance to engage with the Australasian Biobanking community in the stunning city of Hobart – home to a thriving research and education sector. See you there!
Location: Crown Plaza Hobart, Tasmania
Key Dates:
Abstract submission deadline: 14 August 2026
Abstract notifications: late August/early September 2026
Early bird registration deadline: 31 July 2026
FIND OUT MORE

MRFF International Clinical Trial Collaborations
2026-09-16 17:00 (Australia/Sydney)
The objective of the Medical Research Future Fund (MRFF) – 2026 International Clinical Trial Collaborations Grant Opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:

Promote Australian involvement in international collaborative investigator-initiated clinical trials research through the establishment and co-ordination of clinical trial site/s in Australia.
Provide high-quality evidence of the effectiveness of novel health treatments, drugs or devices in ‘usual care’ settings, which will support a decision on whether to deliver the intervention in an Australian setting.

The anticipated outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by investing in new clinical trials that support increased access to high-quality, evidence-based and effective health care.
Please note the 2026 MRFF International Clinical Trial Collaborations grant opportunity will be open for one round only.

Key Dates:
Minimum data due: 19 August 2026
Applications close: 16 September 2026
SEE GRANT GUIDELINESSEE WEBSITE

IAP Congress
2026-10-08 - 2026-10-13 | Fukuoka International Congress Center, 2-1 Sekijōmachi, Fukuoka, 8120032, Japan
It is with great pleasure that we welcome you to the 2026 XXXVI Congress of the International Academy of Pathology in Fukuoka, bringing together the most enthusiastic and dedicated scholars in the field of pathology. Our goal is to create a unique platform where the latest advancements, challenges, and debates in diagnostic and molecular pathology are shared and discussed.
This biennial international congress on pathology will be held jointly with the 72nd Autumn Annual Meeting of the Japanese Society of Pathology, which is held annually in Japan.
As the theme of this year’s congress is “Vision for the Future”, we would like to hold a joint session in the sense of a new challenge that is not bound by the conventional format for the continued development of IAP. Key topics in molecular pathology including spatial transcriptome analysis and artificial intelligence will be explored across various subspecialties, reflecting the evolving landscape of our field. We will also provide the programs on basic issues in pathology such as the educational system and infectious diseases.
Location: Fukuoka International Congress Center, Fukuoka Sunpalace, Fukuoka, Japan
Key Dates:
Abstract Submission Deadline: Friday 10 April 2026, 17:00 (JST)
Young Pathologist Award Application & Abstract Submission: Friday 10 April 2026, 17:00 (JST)
IAP Bursary Abstract Submission: Friday 10 April 2026, 17:00 (JST)
IAP Bursary Application Deadline: Thursday 30 April 2026
Notification of Acceptance: June 2026
FIND OUT MORE

CDMRP Melanoma Research Program
2026-10-14 17:00 (America/Halifax)
The Melanoma Research Program (MRP) released program announcements for the following funding opportunities:

· Focused Program Award – Rare Melanomas
This award supports a multidisciplinary research program of at least two, but not more than three, distinct but complementary research projects addressing an overarching question relevant to rare melanomas.
· Idea Award
The Idea Award supports innovative, exploratory, high-risk/potentially high-reward research. Novelty and innovation are expected to be key aspects of the proposed project. By the end of the Idea Award funding period, the anticipated outcomes of successful efforts should establish proof of principle and obtain preliminary data to secure follow-on funding.
· Melanoma Academy Scholar Award
Supports the addition of independent, early career investigators (Scholars) who are no more than seven years from their initial faculty appointment to the Melanoma Research Program (MRP) Melanoma Academy. The Melanoma Academy is a unique, interactive virtual academy focused on bringing together established investigators and Scholars to develop a network of successful, highly productive melanoma researchers in a collaborative research and career development environment.
· Survivorship Research Award
The award addresses the relatively new and underfunded area of melanoma-specific survivorship by supporting a broad range of innovative and impactful research that has the intended outcome of improving the health and well-being of melanoma survivors, their families and/or their care partners in the near term. Proposed studies focusing exclusively on animal models or considering survival only without consideration of quality of life, overall health and/or function are not responsive to this funding opportunity.
· Team Science Award
Supports a broad range of hypothesis-driven, multidisciplinary studies that have a short-term goal of advancing the state of the science in melanoma research and/or patient care. Team science is a synergistic effort that harnesses techniques, approaches and perspectives from multiple disciplines and/or therapeutic areas to address complex, multi-dimensional problems that will impact patient outcomes.
Key Dates:
Submission Deadline (Pre-application-Pre-Proposal): 13 July 2026
Focused Program Award – Rare Melanomas
Idea Award
Team Science Award
Submission Deadline (Pre-application-Pre-Proposal): 22 September 2026
Melanoma Academy Scholar Award
Survivorship Research Award
Application Submission Deadline: 14 October 2026

SEE GRANT GUIDELINESSEE WEBSITE

ESMO Congress
2026-10-23 - 2026-10-27 | IFEMA Madrid, Avda. Del Partenon, 5, Madrid, 28042, Spain
The ESMO Congress is a highly influential global oncology meeting for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world.
ESMO 2026 will be a platform for breakthroughs in oncology research, clinical practice and patient care. Participants can expect impactful new data, interactive education, excellent networking opportunities and an innovative exhibition area. By attending the ESMO Congress 2026, oncologists will not only gain insights into the latest developments but also play an active role in shaping the future of oncology on a global scale.
A comprehensive educational and scientific programme will foster the exchange and debate of translational cancer science, highlight the first announcements of potentially practice-changing data, and stimulate multidisciplinary discussions aimed at improving treatment options for patients.
Learning objectives:

To stay informed about current approaches in cancer prevention, screening, and early detection
To gain insights into the latest advances in basic, translational, and clinical cancer research
To explore the clinical implications of scientific breakthroughs in cancer biology, diagnostics, and treatment
To be updated on state-of-the-art therapeutic strategies for patients with cancer
To examine the emerging role of artificial intelligence in cancer diagnosis, research and therapy

Location: IFEMA Madrid, Madrid, Spain
Key Dates:
Early Registration Deadline: 22 July 2026 at 23:59 CEST
Abstract Submission Deadline: 12 May 2026 at 21:00 CEST
Late-Breaking Abstract Submission Deadline: 8 September 2026 at 21:00 CEST
Conference Dates: 23 October 2026 – 27 October 2026
FIND OUT MORE

ESSO Congress
2026-11-04 - 2026-11-06 | IFEMA Madrid, Avda. Del Partenon, 5, Madrid, 28042, Spain
The Annual Congress of the European Society of Surgical Oncology (ESSO) is the leading event in Europe dedicated to advancing surgical cancer care.
Bringing together oncology surgeons, researchers, and healthcare professionals from across the globe, the ESSO Congress offers a dynamic platform for sharing cutting-edge research, surgical innovations, and multidisciplinary approaches to cancer treatment.
With a strong focus on education, collaboration, and excellence in patient outcomes, the congress fosters dialogue, drives progress, and shapes the future of surgical oncology.
With the theme Surgical Oncology without Borders: Innovations and Challenges Worldwide, we will explore the latest advancements, global perspectives, and shared challenges that shape the future of Surgical Oncology around the world.
Location: IFEMA Madrid, Spain
Key Dates:
Abstract submission deadline: 6 May 2026
Abstract review results: 6 July 2026
Early registration deadline: 19 August 2026
FIND OUT MORE

SITC Annual Meeting
2026-11-04 - 2026-11-08 | Phoenix Convention Center, 100 N 3rd Street, Phoenix, AZ, United States
SITC 2026 is the premier international conference focused on cancer immunotherapy, bringing together leaders from academia, regulatory agencies, government, and industry for education, scientific exchange, and networking.
The conference provides a multidisciplinary educational and interactive environment focused on improving outcomes for cancer patients by incorporating strategies based on basic and applied cancer immunotherapy.
Why attend SITC 2026?

Cutting-edge sessions by IO experts (Don’t miss over 40 sessions on the latest IO research)
In-person networking opportunities with IO luminaries
Access the latest immuno-oncology research

Location: Phoenix Convention Center, Phoenix, Arizona, United States
Key Dates:
Regular and early career investigator award abstract submission deadline: 25 June 2026
Abstract notifications: 31 July 2026
Late-breaking abstract submission deadline: 10 September 2026
Abstract notifications: 28 September 2026
FIND OUT MORE

IPOS Annual World Congress
2026-11-09 - 2026-11-12 | Hotel Barceló Sants, Pl. dels Països Catalans, s/n, Sants-Montjuïc, Barcelona, 08014, Spain
The annual IPOS World Congress of Psycho-Oncology and Psychosocial Academy brings together professionals in diverse fields from around the globe who dialogue about improving cancer care on an international level and developing strategies to add psychosocial issues to all aspects of cancer control. The attendees include, but are not limited to, psychologists, psychiatrists, physicians, nurses, social workers, social scientists, patient advocates, educators and administrators, dieticians, epidemiologists, spiritual care specialists, and vocational rehabilitation specialists.
The congress offers three days of symposia, podium presentations and posters addressing a variety of disciplines within cancer supportive care. The congress is held in conjunction with the Psychosocial Academy which offers one day of training workshops and presentations.
The theme of the congress is «Towards a sustainable psycho-oncology: of all and for all». In the twenty-first century, there is no longer any doubt about the need to address the psychological aspects of cancer patients and their families, nor about the necessity of incorporating it in patient care throughout the entire cancer journey. It is time to make psycho-oncology a reality across the entire healthcare and social support network for people living with cancer all over the world.

Location: Hotel Barceló Sants, Barcelona, Spain

Key Dates:
Abstract Submission Deadline: 15 July 2026
Abstract Decision Notification: August 2026
Presenting Author Registration and Payment Deadline: 1 October 2026
Workshop Submission Deadline: 1 July 2026
Early Bird Registration Deadline: 11 August 2026
FIND OUT MORE

COSA Annual Scientific Meeting
2026-11-11 - 2026-11-13 | ICC Sydney and Cockle Bay – Darling Harbour, 14 Darling Dr, Sydney, NSW, 2000, Australia
We are honoured to co-convene the 2026 COSA Annual Scientific Meeting (ASM) to be held at the International Convention Centre (ICC) Sydney from Wednesday 11 to Friday 13 November 2026, with pre-conference workshops being held on Tuesday 10 November.
The theme for the 2026 COSA ASM is The precision generation: From cancer prevention to personalised care.

This theme reflects how far cancer care has evolved; from a one-size-fits-all rigid approach, to care that is increasingly tailored to the individual, across the entire cancer journey.
The disease theme will have a strong focus on lung cancers, alongside sessions addressing head and neck cancers, early-onset cancers such as colorectal cancer, and brain cancer, including both primary and metastatic disease. As always, equity will be embedded throughout the program, reflecting COSA’s ongoing commitment to improving outcomes for all people affected by cancer.
It has been almost a decade since the COSA ASM was held in Sydney, so we are excited to bring it back to showcase the remarkable advances that have transformed cancer care over this time, including the molecular biomarker realm and the evolution of novel transformative therapeutics.
Australia has developed deep expertise across clinical care, research and clinical trials, implementation and policy, and the program will highlight this local leadership alongside contributions from international experts in the fields of drug development, precision oncology, pharmacogenomics and palliative and supportive care.

Location: International Convention Centre (ICC), Sydney, Australia
Key Dates:
Delegate Designed Symposia Submissions Close: 3 July 2026
Abstract Submissions Close: 7 August 2026
Abstract Decision Notification: 2 September 2026
Abstract Acceptance by Presenter: 11 September 2026
Early Bird Registration Deadline: 11 September 2026
Pre-conference Workshops: 10 November 2026
FIND OUT MORE

NHMRC Partnership Projects
2026-11-11 17:00 (Australia/Sydney)
The Partnership Project funding scheme provides funding and support to create new opportunities for researchers and policy makers to work together to define research questions, undertake research, interpret the findings and implement the findings into policy and practice.

Partnership Projects create partnerships among decision makers, policy makers, managers, clinicians and researchers and answer a specific research question to influence health and wellbeing through changes in the delivery, organisation, funding and access to health services.
Partnership Projects will support collaborations, within the Australian context, that translate research evidence into health policy and health practice, to improve health services and processes.
The objectives of the Partnership Project scheme are to:
• Meet the need for more effective integration of research evidence into health policy and service delivery
• Create partnerships among policy makers, managers, service providers and researchers
• Provide support to answer often complex and difficult questions that policy makers, managers and service providers face when making decisions and implementing policies that affect Australians’ health and health care
• Be highly responsive to the priorities of government, the community and health professionals
• Enable applicants to apply for funding at any time during the year to allow researchers and Partner Organisations to develop timely collaborations.

Key Dates for Peer Review Cycle 2:
Applications open: 19 March 2026
NHMRC-approved Administering Institutions waiver due: 8 July 2026
Minimum data due: 22 July 2026
Applications close: 5 August 2026
Peer review meetings: 17-19 November 2026
Key Dates for Peer Review Cycle 3:
Applications open: 23 July 2026
NHMRC-approved Administering Institutions waiver due: 14 October 2026
Minimum data due: 28 October 2026
Applications close: 11 November 2026
Peer review meetings: 2-4 March 2027
SEE GRANT GUIDELINESSEE WEBSITE

Australasian Melanoma Conference
2026-11-19 - 2026-11-21 | Sofitel Melbourne on Collins, 25 Collins Street, Melbourne, Victoria, 3000, Australia
The Australasian Melanoma Conference 2026 is a premier event for professionals involved in melanoma and skin cancer research, diagnosis, and clinical management. The conference will present new discoveries from basic science and explore cutting-edge paradigms in melanoma and skin cancer care. It is designed for clinicians, researchers, and healthcare professionals seeking the latest updates in the field and opportunities for networking and collaboration.
The AMC 2026 conference program will feature a broad range of speakers across multi disciplines and concurrent sessions under the key categories of:

Prevention
Early Detection
Advanced Diseases
Survivorship

Location: Sofitel Melbourne on Collins, Melbourne, Australia
Key Dates:
Conference Dates: 19 November 2026 – 21 November 2026
Early Bird Registration Deadline: 31 July 2026
Abstract Submission Deadline: 17 April 2026 at 11:59 PM (AEST)
FIND OUT MORE

Melanoma and Immunotherapy Bridge
2026-11-30 - 2026-12-03 | Royal Continental Hotel Naples, Via Partenope 38/44, Naples, 80121, Italy
Upcoming annual appointments for worldwide cancer clinicians and researchers, gaining more and more attendees every year, the 11th edition of Immunotherapy Bridge and the 16th edition of Melanoma Bridge will be held in Naples (Italy) from November 30th to December 1st and from December 1st to 3rd, respectively.
The first session of Immunotherapy Bridge will be jointly organized with the Society for ImmunoTherapy of Cancer and dedicated to the Modulator of Tumor Immunity and Immunotherapy. An in depth analysis of the drivers of organ specific immune response, the novel drugs development, the actual landscape and future perspectives on the field of cancer vaccines and the neoadjuvant therapies across cancers will follow.
The scientific program of Melanoma Bridge will be dedicated to the most pressing of the unanswered questions, the translational research in melanoma and the most valuable emerging strategies.
Both Immunotherapy and Melanoma Bridge meetings will host a “Great Debate” session, where counterpoint views from leading experts on specific controversial clinical issues will be presented, discussed and evaluated by the audience.

Location: Royal Continental Hotel Naples, Italy

Key Dates
Abstract Submission Deadline: 5 October 2026
Abstract Decision Notification: 30 October 2026
FIND OUT MORE

ASI Annual Scientific Meeting
2026-11-30 - 2026-12-04 | QT Canberra, 1 London Cct, Canberra, 2601, Australia
The ASI 2026 Local Organising Committee warmly invites you to join us for the 54th Annual Scientific Meeting of the Australian and New Zealand Society for Immunology (ASI), to be held 30 November – 4 December 2026 in Canberra (Ngunnawal Country), Australia’s national capital.
Set in one of the world’s most sustainable and liveable cities, Canberra offers the perfect setting for a week of discovery, connection, and scientific excellence. Our comprehensive program will spotlight the leading immunological research from Australia, New Zealand and around the world. The program will include a wide range of topics covering cutting-edge fundamental, translational, and clinical immunology—from infection, inflammation, and autoimmunity to tumour immunology, and immunometabolism.
Our meeting venue, QT Canberra, provides an intimate environment designed to support vibrant discussion and collaboration. Set close to the city centre, on the shores of Lake Burley Griffin, you will be within easy reach to a thriving food and wine scene, national museums and galleries and scenic outdoor spaces providing every opportunity to immerse yourself in the best Canberra has to offer.
We look forward to welcoming you to ASI 2026 in Canberra—a meeting that promises rich scientific exchange, renewed connections, and an engaging celebration of our immunology community.

Location: QT Canberra, Canberra, Australia
Key Dates:
Abstract Submission Deadline: mid-late August 2026
Abstract Decision Notification: Sep – Oct 2026
Early Bird Registration Deadline: mid-late August 2026
Standard Registration Deadline: 23 November 2026

FIND OUT MORE
